Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 220

The DOI matches its Crossref record.

Early Change in Bilirubin Levels Is An Important Prognostic Factor in Severe Alcoholic Hepatitis Treated With Prednisolone

Mathurin, Philippe, Abdelnour, Marcelle, Ramond, Marie-José, Carbonell, Nicolas, Fartoux, Laetitia, Serfaty, Lawrence, Valla, Dominique, Poupon, Raoul, Chaput, Jean-Claude, Naveau, Sylvie·2003·Hepatology

Abstract

Early identification of patients with severe (discriminant function ≥32) biopsy–proven alcoholic hepatitis (AH) who are not responding to corticosteroids would be clinically relevant. Our goal was to develop simple criteria that will help physicians to promptly identify nonresponders to corticosteroids. A total of 238 patients were included. We used 6 months survival as an end point because of the rule requiring 6 months for listing alcoholic patients for transplantation. Overall survival at 1 and 6 months was 85% ± 2.3% and 64.3% ± 3.3%, respectively. An early change in bilirubin levels (ECBL) at 7 days (defined as bilirubin level at 7 days lower than bilirubin level on the first day of treatment) was observed in 73% of patients. At 7 days, in patients with ECBL, bilirubin decreased (84 ± 75 μmol/L [4.94 ± 4.40 mg/dL]), whereas it increased in patients without ECBL (76.5 ± 77 μmol/L [4.50 ± 4.54 mg/dL], P < .0001). Ninety–five percent of patients with ECBL continued to have improved liver function during treatment. At 6 months, survival of patients with ECBL was significantly higher than that of patients without ECBL, 82.8% ± 3.3% versus 23% ± 5.8%, P < .0001. On multivariate analysis, ECBL, discriminant function and creatinine were independent prognostic variables, and ECBL had the most important prognostic value. In conclusion, ECBL is a very simple predictive factor for identifying nonresponders. A recommendation to discontinue corticosteroids after 7 days in patients without ECBL, suggested by our results, awaits additional confirmation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hep.2003.09.038

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 220

Metadata

Authors
Mathurin, P., Abdelnour, M., Ramond, M.-J., Carbonell, N., Fartoux, L., Serfaty, L., Valla, D., Poupon, R., Chaput, J.-C., & Naveau, S.
Venue
Hepatology
Published
2003-12
Volume
38
Issue
6
Pages
1363-1369
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2007334837
Cited by
220
References
0
FWCI
6.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early Change in Bilirubin Levels Is An Important Prognostic Factor in Severe Alcoholic Hepatitis Treated With Prednisolone. https://app.cochat.ai/papers/10.1016/j.hep.2003.09.038
The paper
Mathurin, P., Abdelnour, M., Ramond, M.-J., Carbonell, N., Fartoux, L., Serfaty, L., Valla, D., Poupon, R., Chaput, J.-C., & Naveau, S. (2003). Early Change in Bilirubin Levels Is An Important Prognostic Factor in Severe Alcoholic Hepatitis Treated With Prednisolone. Hepatology. https://doi.org/10.1016/j.hep.2003.09.038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.